1
Wolff Hans Michael, Bouwstra Johanna Aaltje, Li Gai Ling, Nugroho Akhmad Kharis: Iontophoretic delivery of rotigotine for the treatment of parkinsons disease. Schwarz Pharma, HOFFMANN EITLE, June 17, 2004: WO/2004/050083 (7 worldwide citation)

By using a composition comprising rotigotine and at least one chloride salt in a concentration of 1 to 140 mmol/l, the composition having a pH of 4 to 6.5 in a iontophoretic device for the treatment of Parkinson's disease, it became possible to obtain a rotigotine flux across the human stratum corne ...


2
Gai Ling Li, Johanna Aaltje Bouwstra, Hans Michael Wolff, Akhmad Karis Nugroho: Iontophoretic delivery of rotigotine for the treatment of Parkinsons disease. Schwarz Pharma, Harness Dickey & Pierce, December 15, 2009: US07632859 (3 worldwide citation)

By using a composition comprising rotigotine and at least one chloride salt in a concentration of 1 to 140 mmol/l, the composition having a pH of 4 to 6.5 in a iontophoretic device for the treatment of Parkinson's disease, it became possible to obtain a rotigotine flux across the human stratum corne ...


3
Wolff Hans Michael Dr, Bouwstra Johanna Aaltje, Li Gai Ling, Nugroho Akhmad Kharis: Iontophoretic delivery of rotigotine for the treatment of parkinsons disease. Sanol Arznei Schwarz, June 9, 2004: EP1426049-A1

By using a composition comprising rotigotine and at least one chloride salt in a concentration of 1 to 140 mmol/l, the composition having a pH of 4 to 6.5 in a iontophoretic device for the treatment of Parkinson's disease, it became possible to obtain a rotigotine flux across the human stratum corne ...


4

5
Gai Ling Li, Johanna Aaltje Bouwstra, Hans Michael Wolff, Akhmad Kharis Nugroho: Iontophoretic delivery of rotigotine for the treatment of Parkinsons disease. Nath & Associates Pllc, June 17, 2004: US20040116537-A1

By using a composition comprising rotigotine and at least one chloride salt in a concentration of 1 to 140 mmol/l, the composition having a pH of 4 to 6.5 in a iontophoretic device for the treatment of Parkinson's disease, it became possible to obtain a rotigotine flux across the human stratum corne ...


6
Li Gai Ling, Bouwstra Johanna Aaltje, Wolff Hans Michael, Nugroho Akhmad Kharis: Iontophoretic delivery of rotigotine for the treatment of parkinsons disease. Sanol Arznei Schwarz, guan lixin tan mengsheng, January 11, 2006: CN200380104725

By using a composition comprising rotigotine and at least one chloride salt in a concentration of 1 to 140 mmol/l, the composition having a pH of 4 to 6.5 in a iontophoretic device for the treatment of Parkinson's disease, it became possible to obtain a rotigotine flux across the human stratum corne ...


7

8